rs606231454
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_001114748.2(TMEM240):c.239C>T(p.Thr80Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000626 in 1,550,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T80T) has been classified as Benign.
Frequency
Consequence
NM_001114748.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM240 | NM_001114748.2 | c.239C>T | p.Thr80Met | missense_variant | 3/4 | ENST00000378733.9 | NP_001108220.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM240 | ENST00000378733.9 | c.239C>T | p.Thr80Met | missense_variant | 3/4 | 2 | NM_001114748.2 | ENSP00000368007.4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000385 AC: 6AN: 155928Hom.: 0 AF XY: 0.0000483 AC XY: 4AN XY: 82792
GnomAD4 exome AF: 0.0000651 AC: 91AN: 1398198Hom.: 0 Cov.: 33 AF XY: 0.0000595 AC XY: 41AN XY: 689652
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74338
ClinVar
Submissions by phenotype
Spinocerebellar ataxia type 21 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2014 | - - |
Pathogenic, criteria provided, single submitter | research | Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Fondazione Stella Maris | Jan 04, 2021 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | TMEM240: PM2, PS4:Moderate, PS3:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 11, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 161195). This missense change has been observed in individual(s) with spinocerebellar ataxia (PMID: 25070513). In at least one individual the variant was observed to be de novo. This variant is present in population databases (rs606231454, gnomAD 0.009%). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 80 of the TMEM240 protein (p.Thr80Met). - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Feb 06, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at